A study of success rates of clinical drug development analyzed phase transitions in BioMedTracker from 2003 through 2011, including primary and secondary indications. The data set comprised 4,451 drugs from 835 firms. The “likelihood of approval” (LOA) (the probability of a drug reaching FDA approval from its current phase) was 10.4% for phase 1 to […]
Based on preliminary figures, US federal budget authority for R&D fell 7.1% in fiscal year 2013 (FY13) to $133.5 billion due to the sequestration. In FY12, it declined 0.4%. Nondefense R&D budget authority fell 3.6% to $61.5 billion, compared to a 4.4% increase in FY12. By budget function, nondefense budget R&D authority for health, natural […]
Clean energy investments declined 12.1% last year to $254 billion due to the reduced cost of photovoltaic systems and changes in investor confidence as a result of US and European policy changes. In fact, European investments fell 40.9% to $57.8 billion. China, the largest investor, reduced its investments for the first time in more than […]
To start the year, volatility returned to the equity markets as a consequence of mixed corporate earnings and slower jobs growth in the US, financial turmoil in emerging markets and weak manufacturing data for China. Adding to the anxieties, the US Federal Reserve reduced its monthly asset purchases by another $10 billion to $65 billion. […]
Abingdon, England 1/23/14—Oxford Instruments has announced its acquisition of German firm Roentgenanalytik Systeme, a supplier of coating thickness measurement and materials analysis systems using X-ray fluorescence (XRF) spectroscopy. Oxford Instruments stated that the acquisition substantially expands its range of XRF products and that it will make Roentgenanalytik’s headquarters in Taunusstein, Germany, a center of excellence […]
Beijing, China 1/15/14; Beijing, China 1/20/14; Washington, DC 1/31/14— Thermo Fisher Scientific’s proposed acquisition of Life Technologies (see IBO 4/15/13) has received clearance in the US and China. Stating that the merger would have restricted competition in the cell culture products, sequence-specific primer (SSP) kits, protein standards for SDS-PAGE and siRNA reagent markets, China’s Ministry […]
South San Francisco and Sunnyvale, CA 1/29/14—Fluidigm has definitely agreed to acquire DVS Sciences, a provider of multiparameter single-cell protein analysis systems, for $207.5 million in stock and cash. DVS’s mass cytometry technology includes the CyTOF 2 Mass Cytometer, which analyzers antibody/metal complexes using atomic MS. “We believe the acquisition of DVS will increase Fluidigm’s […]
Vélizy-Villacoublay, France and San Diego, CA 1/30/14—Dassault Systèmes, a publicly held 3-D design software company, has signed a definitive agreement to acquire Accelrys, a provider of scientific innovation lifecycle management software. Dassault will make an all cash tender offer for Accelys’s outstanding shares at a price of $12.50 per share, a 28.6% premium over the […]
The annual Society for Laboratory Automation and Screening (SLAS) conference returned to San Diego, California, this year. Attendance at the conference bounced back after last year’s drop when it was held in Florida (see IBO 1/31/13), rising 53% to 5,819, nearly the same as the 2012 event (see IBO 2/15/12) (see table, page 3). SLAS […]
On January 17, more than three months into fiscal year 2014 (FY14), President Obama signed the Consolidated Appropriations Act of 2014. The omnibus bill will fund the federal government at a level of $1.1 trillion and will be effective through September 30. It restores support for many science programs to levels before the FY13 budget […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
